| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth | 51 | 2019 | 355 | 5.800 |
Why?
|
| Asthma | 75 | 2022 | 1003 | 4.960 |
Why?
|
| Trachea | 36 | 2011 | 291 | 2.450 |
Why?
|
| Bronchial Hyperreactivity | 19 | 2020 | 77 | 2.420 |
Why?
|
| Muscle Contraction | 29 | 2019 | 287 | 2.150 |
Why?
|
| Lung | 37 | 2024 | 1337 | 2.060 |
Why?
|
| Bronchi | 29 | 2015 | 232 | 1.850 |
Why?
|
| Bronchoconstriction | 16 | 2024 | 56 | 1.850 |
Why?
|
| Myocytes, Smooth Muscle | 18 | 2020 | 141 | 1.840 |
Why?
|
| Respiratory System | 18 | 2019 | 119 | 1.440 |
Why?
|
| Vitamin D Deficiency | 3 | 2021 | 105 | 1.380 |
Why?
|
| Serum Response Factor | 7 | 2010 | 45 | 1.340 |
Why?
|
| Vitamin D | 2 | 2021 | 269 | 1.180 |
Why?
|
| GATA5 Transcription Factor | 3 | 2014 | 7 | 1.160 |
Why?
|
| Muscle Proteins | 11 | 2018 | 131 | 1.090 |
Why?
|
| Promoter Regions, Genetic | 13 | 2012 | 972 | 1.050 |
Why?
|
| Microfilament Proteins | 10 | 2018 | 212 | 0.880 |
Why?
|
| Muscle, Smooth, Vascular | 8 | 2010 | 242 | 0.820 |
Why?
|
| Respiration | 17 | 2012 | 269 | 0.790 |
Why?
|
| Animals | 114 | 2019 | 28053 | 0.790 |
Why?
|
| Dogs | 28 | 2011 | 705 | 0.770 |
Why?
|
| Airway Obstruction | 7 | 2008 | 110 | 0.700 |
Why?
|
| Cells, Cultured | 33 | 2020 | 2905 | 0.670 |
Why?
|
| Electronic Prescribing | 1 | 2019 | 11 | 0.630 |
Why?
|
| Airway Resistance | 19 | 2024 | 70 | 0.620 |
Why?
|
| Bronchoalveolar Lavage Fluid | 10 | 2017 | 130 | 0.620 |
Why?
|
| Patient Selection | 2 | 2021 | 690 | 0.610 |
Why?
|
| Biomedical Research | 2 | 2021 | 405 | 0.590 |
Why?
|
| Bronchodilator Agents | 7 | 2021 | 66 | 0.590 |
Why?
|
| Methacholine Chloride | 9 | 2024 | 67 | 0.570 |
Why?
|
| Humans | 131 | 2024 | 92339 | 0.560 |
Why?
|
| Tidal Volume | 15 | 2024 | 55 | 0.560 |
Why?
|
| Actins | 8 | 2018 | 469 | 0.530 |
Why?
|
| Phenotype | 18 | 2022 | 2502 | 0.520 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2021 | 279 | 0.510 |
Why?
|
| Salmeterol Xinafoate | 3 | 2021 | 16 | 0.510 |
Why?
|
| Fluticasone | 3 | 2021 | 31 | 0.500 |
Why?
|
| Th2 Cells | 5 | 2019 | 148 | 0.500 |
Why?
|
| Respiratory Physiological Phenomena | 10 | 2004 | 48 | 0.500 |
Why?
|
| Models, Biological | 15 | 2013 | 1786 | 0.500 |
Why?
|
| Pneumonia | 2 | 2014 | 187 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 329 | 0.470 |
Why?
|
| Transforming Growth Factor beta | 4 | 2023 | 329 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 315 | 0.470 |
Why?
|
| Male | 78 | 2024 | 43927 | 0.450 |
Why?
|
| Pandemics | 1 | 2020 | 808 | 0.440 |
Why?
|
| Oxygen | 10 | 1996 | 763 | 0.440 |
Why?
|
| Airway Remodeling | 2 | 2011 | 10 | 0.430 |
Why?
|
| Gene Expression | 9 | 2020 | 1315 | 0.430 |
Why?
|
| Eosinophils | 7 | 2019 | 198 | 0.420 |
Why?
|
| Pulmonary Ventilation | 7 | 2006 | 33 | 0.410 |
Why?
|
| Epithelial Cells | 9 | 2016 | 702 | 0.410 |
Why?
|
| Anti-Asthmatic Agents | 4 | 2014 | 79 | 0.410 |
Why?
|
| RNA, Messenger | 5 | 2009 | 2038 | 0.400 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2012 | 5 | 0.400 |
Why?
|
| E-Box Elements | 1 | 2012 | 5 | 0.400 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 79 | 0.390 |
Why?
|
| Respiratory Mechanics | 5 | 2007 | 103 | 0.390 |
Why?
|
| Cell Nucleus | 3 | 2010 | 613 | 0.390 |
Why?
|
| Glucocorticoids | 3 | 2019 | 367 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 3375 | 0.380 |
Why?
|
| Acetylcholine | 16 | 2018 | 176 | 0.380 |
Why?
|
| MicroRNAs | 6 | 2018 | 575 | 0.380 |
Why?
|
| Ganglia, Spinal | 3 | 1997 | 76 | 0.370 |
Why?
|
| Chromosomes, Mammalian | 1 | 2012 | 38 | 0.370 |
Why?
|
| Signal Transduction | 16 | 2018 | 3509 | 0.370 |
Why?
|
| Guinea Pigs | 19 | 2011 | 171 | 0.370 |
Why?
|
| Myosin Heavy Chains | 5 | 2008 | 91 | 0.360 |
Why?
|
| Female | 59 | 2024 | 47893 | 0.360 |
Why?
|
| Dose-Response Relationship, Drug | 20 | 2019 | 1939 | 0.350 |
Why?
|
| Respiratory Mucosa | 6 | 2014 | 88 | 0.350 |
Why?
|
| Contractile Proteins | 4 | 2011 | 57 | 0.350 |
Why?
|
| Lung Diseases | 4 | 2012 | 283 | 0.350 |
Why?
|
| Receptors, Muscarinic | 5 | 2003 | 48 | 0.350 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2018 | 86 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2014 | 2396 | 0.330 |
Why?
|
| DNA Methylation | 4 | 2020 | 677 | 0.330 |
Why?
|
| Alternative Splicing | 2 | 2009 | 214 | 0.330 |
Why?
|
| RNA Interference | 3 | 2012 | 385 | 0.330 |
Why?
|
| Hyperoxia | 5 | 1996 | 37 | 0.320 |
Why?
|
| Body Temperature Regulation | 7 | 2000 | 57 | 0.320 |
Why?
|
| Capsaicin | 10 | 1997 | 45 | 0.320 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2011 | 47 | 0.320 |
Why?
|
| Mice | 24 | 2015 | 12136 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 98 | 0.320 |
Why?
|
| Alendronate | 2 | 2019 | 17 | 0.310 |
Why?
|
| Respiration, Artificial | 13 | 1994 | 379 | 0.310 |
Why?
|
| Universities | 1 | 2009 | 148 | 0.300 |
Why?
|
| Chicago | 3 | 2021 | 1463 | 0.300 |
Why?
|
| Cyclooxygenase 2 | 3 | 2015 | 99 | 0.300 |
Why?
|
| Pulmonary Gas Exchange | 9 | 1995 | 32 | 0.300 |
Why?
|
| Forced Expiratory Volume | 9 | 2024 | 128 | 0.290 |
Why?
|
| Rats | 21 | 2008 | 4066 | 0.290 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 1724 | 0.290 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2019 | 63 | 0.290 |
Why?
|
| Comorbidity | 2 | 2022 | 986 | 0.290 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2005 | 66 | 0.290 |
Why?
|
| Adult | 44 | 2024 | 27538 | 0.280 |
Why?
|
| Substance P | 3 | 1997 | 62 | 0.280 |
Why?
|
| Mitogens | 2 | 1999 | 61 | 0.280 |
Why?
|
| Steroids | 1 | 2008 | 173 | 0.280 |
Why?
|
| Awards and Prizes | 2 | 2021 | 36 | 0.270 |
Why?
|
| Vitamins | 2 | 2020 | 84 | 0.270 |
Why?
|
| Phosphorylation | 9 | 2011 | 1140 | 0.270 |
Why?
|
| HLA-G Antigens | 4 | 2017 | 52 | 0.260 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1607 | 0.260 |
Why?
|
| Environment | 2 | 2008 | 229 | 0.260 |
Why?
|
| Smad7 Protein | 1 | 2006 | 7 | 0.260 |
Why?
|
| Transcriptional Activation | 5 | 2009 | 298 | 0.250 |
Why?
|
| Middle Aged | 22 | 2021 | 27043 | 0.250 |
Why?
|
| Gene Expression Regulation | 9 | 2020 | 2007 | 0.250 |
Why?
|
| Administration, Inhalation | 7 | 2021 | 193 | 0.240 |
Why?
|
| Bronchial Spasm | 7 | 2016 | 15 | 0.240 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 297 | 0.240 |
Why?
|
| Bronchial Provocation Tests | 7 | 2024 | 25 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 13 | 1997 | 1232 | 0.240 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 315 | 0.230 |
Why?
|
| Interleukin-13 | 2 | 2016 | 41 | 0.230 |
Why?
|
| Asthma, Exercise-Induced | 5 | 2001 | 7 | 0.220 |
Why?
|
| fas Receptor | 2 | 2006 | 78 | 0.220 |
Why?
|
| Catheter Ablation | 1 | 2007 | 257 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 538 | 0.220 |
Why?
|
| Tachykinins | 3 | 1993 | 13 | 0.220 |
Why?
|
| Humidity | 8 | 2004 | 91 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2020 | 2449 | 0.210 |
Why?
|
| Depsipeptides | 3 | 2010 | 29 | 0.210 |
Why?
|
| Neurons | 3 | 1997 | 1596 | 0.200 |
Why?
|
| Immunoglobulin E | 6 | 2017 | 148 | 0.200 |
Why?
|
| Myofibroblasts | 1 | 2023 | 50 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 276 | 0.200 |
Why?
|
| Protein Kinases | 1 | 2004 | 216 | 0.200 |
Why?
|
| ADP-ribosyl Cyclase 1 | 3 | 2012 | 19 | 0.200 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 161 | 0.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 707 | 0.200 |
Why?
|
| Japan | 1 | 2022 | 306 | 0.190 |
Why?
|
| Microbiota | 2 | 2019 | 412 | 0.190 |
Why?
|
| Cell Division | 9 | 2003 | 702 | 0.190 |
Why?
|
| Microscopy | 2 | 2019 | 88 | 0.190 |
Why?
|
| Transcription, Genetic | 7 | 2006 | 1164 | 0.190 |
Why?
|
| Cytokines | 4 | 2020 | 843 | 0.190 |
Why?
|
| Neuropeptides | 2 | 1992 | 114 | 0.180 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2001 | 74 | 0.180 |
Why?
|
| Allergens | 5 | 2005 | 189 | 0.180 |
Why?
|
| Bronchoconstrictor Agents | 4 | 2024 | 13 | 0.180 |
Why?
|
| Financial Management | 1 | 2021 | 21 | 0.180 |
Why?
|
| Genome, Human | 3 | 2003 | 803 | 0.180 |
Why?
|
| Epithelium | 10 | 1996 | 324 | 0.180 |
Why?
|
| Papillary Muscles | 1 | 2001 | 18 | 0.180 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 206 | 0.180 |
Why?
|
| Transfection | 4 | 2009 | 901 | 0.180 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 105 | 0.170 |
Why?
|
| Neutrophils | 3 | 2019 | 323 | 0.170 |
Why?
|
| Calcifediol | 1 | 2020 | 20 | 0.170 |
Why?
|
| Animals, Newborn | 6 | 2019 | 524 | 0.170 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2008 | 97 | 0.170 |
Why?
|
| Thiazoles | 3 | 2008 | 128 | 0.170 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 301 | 0.170 |
Why?
|
| Hyperventilation | 5 | 1993 | 14 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2023 | 768 | 0.170 |
Why?
|
| Social Class | 1 | 2021 | 138 | 0.170 |
Why?
|
| Stress, Mechanical | 6 | 2019 | 256 | 0.170 |
Why?
|
| Down-Regulation | 6 | 2018 | 524 | 0.170 |
Why?
|
| Education, Medical, Continuing | 1 | 2021 | 106 | 0.170 |
Why?
|
| Binding Sites | 5 | 2012 | 1131 | 0.170 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 77 | 0.170 |
Why?
|
| Ovalbumin | 5 | 2014 | 109 | 0.170 |
Why?
|
| Aerosols | 7 | 2008 | 47 | 0.170 |
Why?
|
| Traction | 1 | 2019 | 6 | 0.160 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2020 | 57 | 0.160 |
Why?
|
| Respiration Disorders | 2 | 1993 | 40 | 0.160 |
Why?
|
| Chromosome Mapping | 5 | 2004 | 1078 | 0.160 |
Why?
|
| Consumer Health Informatics | 1 | 2019 | 3 | 0.160 |
Why?
|
| Minority Groups | 1 | 2021 | 151 | 0.160 |
Why?
|
| Calcitriol | 1 | 2020 | 173 | 0.160 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 25 | 0.160 |
Why?
|
| Nasal Mucosa | 5 | 2004 | 190 | 0.160 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 1995 | 40 | 0.160 |
Why?
|
| Disease Models, Animal | 7 | 2014 | 2449 | 0.150 |
Why?
|
| Cell Cycle | 3 | 1995 | 516 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 1249 | 0.150 |
Why?
|
| Nasal Cavity | 4 | 2004 | 88 | 0.150 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 39 | 0.150 |
Why?
|
| Fungi | 1 | 2019 | 67 | 0.150 |
Why?
|
| Caspase 7 | 1 | 2018 | 15 | 0.150 |
Why?
|
| Gases | 5 | 1994 | 31 | 0.150 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 651 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2010 | 227 | 0.150 |
Why?
|
| Hypercapnia | 1 | 2018 | 46 | 0.150 |
Why?
|
| Focus Groups | 1 | 2019 | 186 | 0.150 |
Why?
|
| Cellular Structures | 1 | 2018 | 3 | 0.150 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2015 | 26 | 0.150 |
Why?
|
| Lysophospholipids | 2 | 2009 | 66 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1998 | 107 | 0.140 |
Why?
|
| United States | 8 | 2021 | 7348 | 0.140 |
Why?
|
| Forced Expiratory Flow Rates | 2 | 1988 | 4 | 0.140 |
Why?
|
| Genotype | 7 | 2014 | 1865 | 0.140 |
Why?
|
| S Phase | 2 | 1995 | 64 | 0.140 |
Why?
|
| Cold Temperature | 7 | 1995 | 161 | 0.140 |
Why?
|
| Molecular Sequence Data | 9 | 2009 | 3018 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2005 | 41 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 4 | 2006 | 1399 | 0.140 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 1016 | 0.140 |
Why?
|
| DNA | 4 | 2020 | 1314 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2019 | 273 | 0.140 |
Why?
|
| Hypertrophy | 5 | 2011 | 67 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2015 | 125 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 474 | 0.140 |
Why?
|
| Thiazolidines | 3 | 2008 | 18 | 0.140 |
Why?
|
| Genes, Reporter | 2 | 2009 | 277 | 0.140 |
Why?
|
| Enzyme Activation | 9 | 2018 | 698 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 2793 | 0.130 |
Why?
|
| Calcium Channel Blockers | 3 | 2011 | 121 | 0.130 |
Why?
|
| Actin Cytoskeleton | 3 | 2009 | 199 | 0.130 |
Why?
|
| Temperature | 5 | 2003 | 405 | 0.130 |
Why?
|
| Piperidines | 3 | 2000 | 164 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 886 | 0.130 |
Why?
|
| In Vitro Techniques | 11 | 2004 | 998 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2018 | 185 | 0.130 |
Why?
|
| Receptors, Neurotransmitter | 2 | 1993 | 26 | 0.130 |
Why?
|
| Retrospective Studies | 2 | 2021 | 9689 | 0.130 |
Why?
|
| Incidence | 1 | 2021 | 1661 | 0.130 |
Why?
|
| Pulmonary Emphysema | 1 | 1996 | 39 | 0.130 |
Why?
|
| Quantitative Trait Loci | 3 | 2020 | 628 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 364 | 0.120 |
Why?
|
| Hot Temperature | 4 | 2003 | 213 | 0.120 |
Why?
|
| Benzamides | 2 | 1995 | 239 | 0.120 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Histamine | 6 | 2011 | 125 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2000 | 736 | 0.120 |
Why?
|
| Base Sequence | 8 | 2009 | 2319 | 0.120 |
Why?
|
| Neurons, Afferent | 2 | 1994 | 78 | 0.120 |
Why?
|
| Body Temperature | 5 | 2001 | 127 | 0.120 |
Why?
|
| Body Water | 3 | 1991 | 35 | 0.120 |
Why?
|
| 3' Untranslated Regions | 3 | 2012 | 96 | 0.120 |
Why?
|
| Lod Score | 3 | 2012 | 153 | 0.120 |
Why?
|
| Double-Blind Method | 6 | 2019 | 1756 | 0.120 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 82 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2007 | 205 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2015 | 472 | 0.120 |
Why?
|
| Young Adult | 7 | 2024 | 6630 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 2002 | 392 | 0.120 |
Why?
|
| Hypersensitivity | 3 | 2007 | 163 | 0.120 |
Why?
|
| ELAV Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 180 | 0.110 |
Why?
|
| Nedocromil | 1 | 2014 | 6 | 0.110 |
Why?
|
| HLA Antigens | 2 | 2007 | 227 | 0.110 |
Why?
|
| Apoptosis | 2 | 2007 | 1745 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 280 | 0.110 |
Why?
|
| Air | 3 | 2001 | 62 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 60 | 0.110 |
Why?
|
| alpha-N-Acetylgalactosaminidase | 1 | 2014 | 4 | 0.110 |
Why?
|
| Exons | 2 | 2009 | 453 | 0.110 |
Why?
|
| Research | 1 | 2015 | 254 | 0.110 |
Why?
|
| Biomechanical Phenomena | 6 | 2019 | 488 | 0.110 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 282 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2014 | 17 | 0.110 |
Why?
|
| Pregnenediones | 1 | 2014 | 8 | 0.110 |
Why?
|
| Child | 12 | 2021 | 7309 | 0.110 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2014 | 17 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2008 | 202 | 0.110 |
Why?
|
| Goblet Cells | 1 | 2014 | 20 | 0.110 |
Why?
|
| Protein Binding | 3 | 2010 | 1514 | 0.110 |
Why?
|
| Metaplasia | 1 | 2014 | 37 | 0.110 |
Why?
|
| Adolescent | 11 | 2021 | 9495 | 0.110 |
Why?
|
| Cholecalciferol | 1 | 2014 | 35 | 0.110 |
Why?
|
| Blood Volume | 1 | 1994 | 45 | 0.110 |
Why?
|
| Risk Factors | 3 | 2020 | 5706 | 0.110 |
Why?
|
| Eicosanoids | 1 | 1993 | 16 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2021 | 2978 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2014 | 36 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2023 | 87 | 0.110 |
Why?
|
| Calcium | 4 | 2018 | 1183 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2014 | 2097 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 693 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 1595 | 0.110 |
Why?
|
| Pulmonary Circulation | 3 | 1990 | 92 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 149 | 0.110 |
Why?
|
| Sepsis | 1 | 2017 | 351 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 131 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2021 | 2368 | 0.100 |
Why?
|
| Therapies, Investigational | 1 | 2013 | 17 | 0.100 |
Why?
|
| Carbon Dioxide | 7 | 2018 | 205 | 0.100 |
Why?
|
| Aged | 9 | 2020 | 19951 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 1993 | 61 | 0.100 |
Why?
|
| Inflammation | 6 | 2014 | 1024 | 0.100 |
Why?
|
| RNA, Small Interfering | 4 | 2023 | 562 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 1993 | 108 | 0.100 |
Why?
|
| Pedigree | 4 | 2009 | 966 | 0.100 |
Why?
|
| Verapamil | 3 | 2011 | 34 | 0.100 |
Why?
|
| Case-Control Studies | 6 | 2016 | 1901 | 0.100 |
Why?
|
| Dilatation | 1 | 2012 | 47 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2012 | 439 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 317 | 0.090 |
Why?
|
| Rhinitis, Allergic, Seasonal | 4 | 2001 | 179 | 0.090 |
Why?
|
| KCNQ Potassium Channels | 1 | 2011 | 7 | 0.090 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 172 | 0.090 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 53 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 160 | 0.090 |
Why?
|
| Cell Line | 4 | 2010 | 2505 | 0.090 |
Why?
|
| Helium | 3 | 1993 | 10 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 13 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 888 | 0.090 |
Why?
|
| Bronchoscopy | 3 | 2008 | 166 | 0.090 |
Why?
|
| Plakins | 1 | 2011 | 1 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 461 | 0.090 |
Why?
|
| alpha Karyopherins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Blotting, Northern | 2 | 2009 | 258 | 0.090 |
Why?
|
| Myofibrils | 1 | 2011 | 22 | 0.090 |
Why?
|
| Bromodeoxyuridine | 3 | 1995 | 58 | 0.090 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1995 | 86 | 0.090 |
Why?
|
| Methacholine Compounds | 5 | 1994 | 16 | 0.090 |
Why?
|
| Plethysmography | 2 | 2008 | 17 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2011 | 324 | 0.090 |
Why?
|
| Dimerization | 1 | 2010 | 145 | 0.090 |
Why?
|
| Potassium Chloride | 3 | 2009 | 87 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 140 | 0.090 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 2 | 1987 | 2 | 0.090 |
Why?
|
| Receptors, Tachykinin | 3 | 1995 | 9 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2009 | 794 | 0.080 |
Why?
|
| Mutation | 3 | 2010 | 4212 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2008 | 1805 | 0.080 |
Why?
|
| Butadienes | 1 | 2010 | 34 | 0.080 |
Why?
|
| Budesonide | 2 | 2014 | 46 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 2 | 2000 | 22 | 0.080 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2009 | 31 | 0.080 |
Why?
|
| Training Support | 1 | 2009 | 23 | 0.080 |
Why?
|
| Neurokinin A | 3 | 1995 | 12 | 0.080 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2009 | 6 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 307 | 0.080 |
Why?
|
| 5' Flanking Region | 1 | 2009 | 16 | 0.080 |
Why?
|
| Genetic Variation | 4 | 2012 | 1392 | 0.080 |
Why?
|
| Community-Institutional Relations | 1 | 2009 | 29 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2009 | 39 | 0.080 |
Why?
|
| Cell Enlargement | 1 | 2009 | 5 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1724 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2014 | 87 | 0.080 |
Why?
|
| Transcription Initiation Site | 1 | 2009 | 47 | 0.080 |
Why?
|
| Nose | 2 | 2000 | 95 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 295 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 2 | 2004 | 45 | 0.080 |
Why?
|
| Smooth Muscle Myosins | 1 | 2009 | 5 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 111 | 0.080 |
Why?
|
| Nitriles | 1 | 2010 | 158 | 0.080 |
Why?
|
| Gastric Mucosa | 1 | 2009 | 68 | 0.080 |
Why?
|
| Glycopeptides | 1 | 1989 | 18 | 0.080 |
Why?
|
| Maximal Expiratory Flow Rate | 2 | 1988 | 2 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 441 | 0.080 |
Why?
|
| Aminophylline | 1 | 1989 | 14 | 0.080 |
Why?
|
| Terbutaline | 1 | 1989 | 16 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 559 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2000 | 284 | 0.080 |
Why?
|
| Kinetics | 6 | 1995 | 1552 | 0.080 |
Why?
|
| Air Conditioning | 1 | 1988 | 6 | 0.080 |
Why?
|
| Lung Injury | 1 | 2009 | 57 | 0.080 |
Why?
|
| Nitrogen | 1 | 1989 | 75 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 336 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 36 | 0.070 |
Why?
|
| Nifedipine | 2 | 1985 | 26 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2008 | 41 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 284 | 0.070 |
Why?
|
| Introns | 1 | 2009 | 302 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2008 | 73 | 0.070 |
Why?
|
| Cross-Over Studies | 4 | 2019 | 391 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2008 | 80 | 0.070 |
Why?
|
| Receptor, Muscarinic M3 | 3 | 2003 | 12 | 0.070 |
Why?
|
| Protein Kinase C | 4 | 2008 | 266 | 0.070 |
Why?
|
| Endothelin-1 | 2 | 2009 | 40 | 0.070 |
Why?
|
| Time Factors | 8 | 2014 | 5429 | 0.070 |
Why?
|
| Biological Transport | 4 | 2000 | 410 | 0.070 |
Why?
|
| Propranolol | 4 | 1994 | 44 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 232 | 0.070 |
Why?
|
| rho-Associated Kinases | 2 | 2013 | 161 | 0.070 |
Why?
|
| Vagus Nerve | 2 | 1986 | 49 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 815 | 0.070 |
Why?
|
| Aging | 2 | 2008 | 741 | 0.070 |
Why?
|
| Cell Communication | 3 | 1999 | 206 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2019 | 3805 | 0.070 |
Why?
|
| Pulmonary Alveoli | 3 | 1996 | 72 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2006 | 474 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2007 | 56 | 0.070 |
Why?
|
| Chronic Disease | 4 | 2018 | 966 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 259 | 0.060 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2006 | 12 | 0.060 |
Why?
|
| Hyperthermia, Induced | 1 | 2007 | 74 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2006 | 30 | 0.060 |
Why?
|
| Elasticity | 2 | 2004 | 101 | 0.060 |
Why?
|
| Genomics | 1 | 2012 | 807 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 89 | 0.060 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 24 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 86 | 0.060 |
Why?
|
| Communication | 1 | 2009 | 462 | 0.060 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1997 | 39 | 0.060 |
Why?
|
| Genetic Markers | 3 | 2001 | 475 | 0.060 |
Why?
|
| Age Factors | 3 | 2014 | 1903 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 29 | 0.060 |
Why?
|
| Functional Residual Capacity | 2 | 2024 | 4 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2014 | 1108 | 0.060 |
Why?
|
| Fourier Analysis | 2 | 2016 | 128 | 0.060 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2005 | 11 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2016 | 81 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2005 | 32 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2008 | 498 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 221 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 3 | 2012 | 200 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2005 | 211 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 109 | 0.060 |
Why?
|
| Myosins | 2 | 2008 | 94 | 0.060 |
Why?
|
| Ipratropium | 2 | 2003 | 18 | 0.060 |
Why?
|
| Lung Volume Measurements | 5 | 1992 | 21 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 177 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2004 | 36 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2004 | 128 | 0.060 |
Why?
|
| Cockroaches | 2 | 2003 | 10 | 0.060 |
Why?
|
| Anoctamin-1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 12 | 0.050 |
Why?
|
| Albuterol | 1 | 2004 | 35 | 0.050 |
Why?
|
| Education | 2 | 2015 | 58 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1998 | 2075 | 0.050 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2004 | 43 | 0.050 |
Why?
|
| Rhinitis, Allergic, Perennial | 2 | 2001 | 81 | 0.050 |
Why?
|
| Lymphotoxin-alpha | 1 | 2003 | 43 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2024 | 146 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 155 | 0.050 |
Why?
|
| Clone Cells | 1 | 2003 | 214 | 0.050 |
Why?
|
| Skin Temperature | 1 | 2003 | 15 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 86 | 0.050 |
Why?
|
| Chlorides | 1 | 2023 | 104 | 0.050 |
Why?
|
| Interferon-gamma | 3 | 2014 | 454 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 112 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 208 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 741 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 786 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2004 | 224 | 0.050 |
Why?
|
| Foot | 1 | 2003 | 56 | 0.050 |
Why?
|
| Reflex | 1 | 2003 | 80 | 0.050 |
Why?
|
| Muscle Cells | 1 | 2003 | 18 | 0.050 |
Why?
|
| Amides | 1 | 2003 | 56 | 0.050 |
Why?
|
| Artifacts | 1 | 2004 | 246 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2003 | 168 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2004 | 210 | 0.050 |
Why?
|
| Genetic Linkage | 2 | 2001 | 623 | 0.050 |
Why?
|
| Skin Tests | 4 | 2003 | 44 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 431 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2005 | 283 | 0.050 |
Why?
|
| Up-Regulation | 4 | 2015 | 729 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 167 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 286 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 115 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 319 | 0.050 |
Why?
|
| Stem Cells | 1 | 2004 | 382 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 1847 | 0.050 |
Why?
|
| Supine Position | 1 | 2001 | 32 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2004 | 298 | 0.050 |
Why?
|
| Cell Movement | 1 | 2005 | 801 | 0.050 |
Why?
|
| Capillary Permeability | 2 | 1993 | 133 | 0.050 |
Why?
|
| Haplotypes | 4 | 2009 | 639 | 0.050 |
Why?
|
| Hemoglobins | 2 | 1979 | 190 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 351 | 0.050 |
Why?
|
| Respiratory Function Tests | 4 | 2007 | 145 | 0.050 |
Why?
|
| Antigens, Helminth | 2 | 2006 | 22 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2003 | 374 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2002 | 358 | 0.040 |
Why?
|
| Eosinophilia | 2 | 2015 | 86 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 68 | 0.040 |
Why?
|
| NF-kappa B | 3 | 2012 | 468 | 0.040 |
Why?
|
| Immunization | 3 | 2000 | 163 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1996 | 332 | 0.040 |
Why?
|
| Cats | 2 | 1998 | 305 | 0.040 |
Why?
|
| Transcription Factor AP-2 | 1 | 2000 | 14 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 1998 | 643 | 0.040 |
Why?
|
| Pyridines | 1 | 2003 | 312 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 390 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 2000 | 70 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2020 | 13 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2000 | 59 | 0.040 |
Why?
|
| Serine | 1 | 2000 | 105 | 0.040 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2000 | 9 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2000 | 73 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 234 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 90 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2014 | 497 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2013 | 902 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 1999 | 84 | 0.040 |
Why?
|
| Lipoxygenase Inhibitors | 3 | 1994 | 36 | 0.040 |
Why?
|
| Rabbits | 1 | 2000 | 645 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 806 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2001 | 899 | 0.040 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 827 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 201 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2000 | 313 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2003 | 969 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 1279 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 866 | 0.040 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 1989 | 13 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 206 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 51 | 0.040 |
Why?
|
| MEF2 Transcription Factors | 1 | 2018 | 10 | 0.040 |
Why?
|
| Constriction, Pathologic | 3 | 1988 | 219 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 108 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 1998 | 36 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 65 | 0.040 |
Why?
|
| Potoroidae | 1 | 2018 | 4 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6920 | 0.040 |
Why?
|
| Growth Substances | 2 | 1995 | 80 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 876 | 0.040 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2018 | 5 | 0.040 |
Why?
|
| High-Frequency Ventilation | 2 | 1995 | 10 | 0.040 |
Why?
|
| Mathematics | 4 | 1987 | 191 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 123 | 0.040 |
Why?
|
| Atropine | 3 | 2000 | 60 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 607 | 0.040 |
Why?
|
| COS Cells | 1 | 1998 | 167 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2018 | 35 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1979 | 233 | 0.040 |
Why?
|
| Luciferases | 1 | 1998 | 129 | 0.040 |
Why?
|
| Cytochalasin B | 1 | 1997 | 19 | 0.040 |
Why?
|
| Calpain | 1 | 2018 | 113 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 1997 | 25 | 0.040 |
Why?
|
| Biopsy | 2 | 2008 | 1194 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1995 | 78 | 0.040 |
Why?
|
| Prevalence | 2 | 2018 | 1298 | 0.040 |
Why?
|
| Polylysine | 1 | 1997 | 34 | 0.040 |
Why?
|
| Myelin Basic Protein | 1 | 1997 | 47 | 0.040 |
Why?
|
| Listeriosis | 1 | 2018 | 88 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2018 | 94 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 312 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 281 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1997 | 53 | 0.030 |
Why?
|
| Air Pressure | 2 | 1994 | 7 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 2010 | 65 | 0.030 |
Why?
|
| Cell Survival | 3 | 2014 | 1008 | 0.030 |
Why?
|
| Rural Population | 1 | 2018 | 151 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1997 | 177 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 670 | 0.030 |
Why?
|
| Serotonin | 2 | 1995 | 219 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2019 | 4471 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 514 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2000 | 684 | 0.030 |
Why?
|
| Vasodilator Agents | 2 | 2012 | 146 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1996 | 32 | 0.030 |
Why?
|
| Reference Values | 3 | 2003 | 660 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 390 | 0.030 |
Why?
|
| Electric Stimulation | 4 | 1995 | 371 | 0.030 |
Why?
|
| Image Cytometry | 1 | 2016 | 12 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1998 | 476 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 154 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1998 | 379 | 0.030 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1996 | 41 | 0.030 |
Why?
|
| Leukocyte Count | 2 | 1995 | 225 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 1995 | 41 | 0.030 |
Why?
|
| Blood Proteins | 2 | 2000 | 149 | 0.030 |
Why?
|
| Water | 2 | 2003 | 292 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2003 | 198 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 855 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 280 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.030 |
Why?
|
| Bronchography | 3 | 1990 | 11 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2015 | 93 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1995 | 24 | 0.030 |
Why?
|
| Alleles | 3 | 2007 | 1142 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1996 | 119 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 111 | 0.030 |
Why?
|
| Mannitol | 1 | 1995 | 51 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 1995 | 35 | 0.030 |
Why?
|
| Ascaris suum | 1 | 1995 | 10 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 270 | 0.030 |
Why?
|
| Organ Size | 2 | 1993 | 374 | 0.030 |
Why?
|
| Glycerol | 1 | 1995 | 35 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 109 | 0.030 |
Why?
|
| Sucrose | 1 | 1995 | 65 | 0.030 |
Why?
|
| Antigens | 1 | 1996 | 228 | 0.030 |
Why?
|
| Tantalum | 2 | 1994 | 5 | 0.030 |
Why?
|
| Glaucoma | 1 | 2015 | 35 | 0.030 |
Why?
|
| Pressure | 4 | 1988 | 169 | 0.030 |
Why?
|
| Surface Tension | 2 | 1994 | 8 | 0.030 |
Why?
|
| RNA Stability | 1 | 2015 | 92 | 0.030 |
Why?
|
| Costa Rica | 1 | 2014 | 15 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 1072 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 1998 | 375 | 0.030 |
Why?
|
| Rho Factor | 1 | 2014 | 2 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1994 | 19 | 0.030 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2014 | 4 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 81 | 0.030 |
Why?
|
| Freezing | 1 | 2014 | 32 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 85 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 56 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 1994 | 37 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2014 | 28 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1994 | 89 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 39 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2014 | 75 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2015 | 110 | 0.030 |
Why?
|
| Evans Blue | 1 | 1993 | 5 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1994 | 160 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 531 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2014 | 72 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 509 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 175 | 0.030 |
Why?
|
| Lung Compliance | 3 | 1988 | 15 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 69 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2014 | 79 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 1994 | 84 | 0.030 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1993 | 3 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 93 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1995 | 170 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 102 | 0.030 |
Why?
|
| HSP20 Heat-Shock Proteins | 1 | 2013 | 1 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1993 | 22 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2014 | 288 | 0.030 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2013 | 5 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2014 | 131 | 0.030 |
Why?
|
| Biological Products | 1 | 1996 | 171 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 122 | 0.030 |
Why?
|
| Esophagus | 1 | 1993 | 107 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1995 | 466 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 261 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2013 | 33 | 0.030 |
Why?
|
| Linear Models | 1 | 1994 | 427 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2005 | 305 | 0.030 |
Why?
|
| Body Weight | 1 | 1994 | 456 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 1993 | 62 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 547 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 60 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 251 | 0.020 |
Why?
|
| Linkage Disequilibrium | 2 | 2007 | 478 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 672 | 0.020 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 2 | 1989 | 3 | 0.020 |
Why?
|
| Nuclear Family | 2 | 2003 | 94 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 249 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2005 | 173 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2000 | 1689 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 86 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 303 | 0.020 |
Why?
|
| Vital Capacity | 2 | 1990 | 69 | 0.020 |
Why?
|
| Administration, Intranasal | 2 | 2004 | 139 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 923 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1992 | 49 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 137 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2012 | 41 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 311 | 0.020 |
Why?
|
| Cadaver | 1 | 2012 | 191 | 0.020 |
Why?
|
| Weight Gain | 1 | 1992 | 124 | 0.020 |
Why?
|
| Catheterization | 1 | 1993 | 237 | 0.020 |
Why?
|
| Phenylenediamines | 1 | 2011 | 7 | 0.020 |
Why?
|
| Anthracenes | 1 | 2011 | 16 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2012 | 71 | 0.020 |
Why?
|
| Carbamates | 1 | 2011 | 16 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1993 | 251 | 0.020 |
Why?
|
| Celecoxib | 1 | 2011 | 33 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 87 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 501 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 700 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2011 | 45 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 131 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 45 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1505 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1994 | 1270 | 0.020 |
Why?
|
| Ferrets | 1 | 1990 | 48 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1117 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 72 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 249 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2011 | 154 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 397 | 0.020 |
Why?
|
| Cattle | 3 | 1995 | 381 | 0.020 |
Why?
|
| Body Fluids | 1 | 1990 | 34 | 0.020 |
Why?
|
| Viscosity | 1 | 1990 | 49 | 0.020 |
Why?
|
| Proteins | 1 | 1996 | 803 | 0.020 |
Why?
|
| Ribonucleases | 1 | 1990 | 94 | 0.020 |
Why?
|
| Inspiratory Capacity | 1 | 1990 | 2 | 0.020 |
Why?
|
| Heart Rate | 1 | 1992 | 502 | 0.020 |
Why?
|
| Europe | 2 | 2001 | 328 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 128 | 0.020 |
Why?
|
| Ribosomal Protein S6 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 763 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 189 | 0.020 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2009 | 14 | 0.020 |
Why?
|
| Indomethacin | 3 | 1994 | 59 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2009 | 22 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2009 | 33 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 97 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 29 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2003 | 696 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 328 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 391 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 538 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2004 | 550 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 212 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 161 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 376 | 0.020 |
Why?
|
| Vagotomy | 1 | 1988 | 12 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2008 | 205 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 154 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 268 | 0.020 |
Why?
|
| Phospholipase D | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cadherins | 1 | 2009 | 165 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2008 | 33 | 0.020 |
Why?
|
| Electronics, Medical | 1 | 1987 | 4 | 0.020 |
Why?
|
| SRS-A | 1 | 1987 | 27 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2009 | 902 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2007 | 91 | 0.020 |
Why?
|
| Schistosomiasis | 1 | 2006 | 5 | 0.020 |
Why?
|
| Brain | 2 | 2005 | 2355 | 0.020 |
Why?
|
| Schistosoma mansoni | 1 | 2006 | 17 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2007 | 160 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2006 | 17 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2006 | 52 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2007 | 219 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 122 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2005 | 5 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 173 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 70 | 0.020 |
Why?
|
| Intubation | 1 | 1985 | 22 | 0.010 |
Why?
|
| Thermometers | 1 | 1985 | 6 | 0.010 |
Why?
|
| Cromolyn Sodium | 1 | 1984 | 3 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 108 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1985 | 36 | 0.010 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2004 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 7 | 0.010 |
Why?
|
| Uterus | 1 | 2006 | 222 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1995 | 115 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1986 | 330 | 0.010 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2003 | 15 | 0.010 |
Why?
|
| Physiology | 1 | 1984 | 17 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2005 | 244 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2003 | 39 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 2003 | 34 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1986 | 183 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2004 | 140 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 192 | 0.010 |
Why?
|
| Oncogenes | 1 | 2003 | 99 | 0.010 |
Why?
|
| Phenoxybenzamine | 1 | 2003 | 15 | 0.010 |
Why?
|
| Immersion | 1 | 2003 | 21 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 2003 | 32 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2003 | 31 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2007 | 478 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2003 | 28 | 0.010 |
Why?
|
| Response Elements | 1 | 2003 | 65 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2003 | 29 | 0.010 |
Why?
|
| Lidocaine | 1 | 2003 | 67 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2006 | 334 | 0.010 |
Why?
|
| Argon | 2 | 1993 | 10 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 99 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 200 | 0.010 |
Why?
|
| Infant | 2 | 2004 | 3207 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1987 | 1112 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2003 | 82 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1984 | 152 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 280 | 0.010 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 181 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 708 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 3776 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 40 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2001 | 65 | 0.010 |
Why?
|
| Africa | 1 | 2001 | 102 | 0.010 |
Why?
|
| South Dakota | 1 | 2000 | 47 | 0.010 |
Why?
|
| Nasal Provocation Tests | 1 | 2000 | 129 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 1228 | 0.010 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 12 | 0.010 |
Why?
|
| Pirenzepine | 1 | 2000 | 8 | 0.010 |
Why?
|
| Fura-2 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Diamines | 1 | 2000 | 11 | 0.010 |
Why?
|
| Oxazoles | 1 | 2000 | 18 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2000 | 19 | 0.010 |
Why?
|
| Macrocyclic Compounds | 1 | 2000 | 8 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2000 | 17 | 0.010 |
Why?
|
| Bradykinin | 1 | 2000 | 46 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2000 | 24 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 110 | 0.010 |
Why?
|
| Christianity | 1 | 2000 | 37 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 640 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 79 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 2000 | 59 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 123 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 158 | 0.010 |
Why?
|
| Transferrin | 1 | 1979 | 21 | 0.010 |
Why?
|
| Haplorhini | 1 | 1979 | 80 | 0.010 |
Why?
|
| Nasopharynx | 1 | 1999 | 51 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 1998 | 2 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2000 | 182 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1998 | 127 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 260 | 0.010 |
Why?
|
| Hemoglobin A | 1 | 1978 | 8 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 120 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2506 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 206 | 0.010 |
Why?
|
| Species Specificity | 1 | 1979 | 693 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1979 | 468 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 29 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 126 | 0.010 |
Why?
|
| Tromethamine | 1 | 1995 | 4 | 0.010 |
Why?
|
| Pulmonary Surfactants | 1 | 1996 | 22 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1995 | 34 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1996 | 82 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 48 | 0.010 |
Why?
|
| Thymidine | 1 | 1995 | 59 | 0.010 |
Why?
|
| Multigene Family | 1 | 1996 | 203 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 420 | 0.010 |
Why?
|
| Fetus | 1 | 1996 | 234 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 118 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1995 | 198 | 0.010 |
Why?
|
| Blood | 1 | 1995 | 68 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 103 | 0.010 |
Why?
|
| Tyrosine | 1 | 1994 | 133 | 0.010 |
Why?
|
| Vacuum | 1 | 1994 | 10 | 0.010 |
Why?
|
| DNA Replication | 1 | 1995 | 174 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1994 | 62 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 49 | 0.010 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1994 | 10 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1996 | 346 | 0.010 |
Why?
|
| Pleura | 1 | 1994 | 31 | 0.010 |
Why?
|
| Polyethylenes | 1 | 1993 | 7 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1993 | 48 | 0.010 |
Why?
|
| Lipoxygenase | 1 | 1993 | 8 | 0.010 |
Why?
|
| Phenyl Ethers | 1 | 1993 | 13 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1993 | 50 | 0.010 |
Why?
|
| Acetamides | 1 | 1993 | 27 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1993 | 36 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 271 | 0.010 |
Why?
|
| Random Allocation | 1 | 1993 | 328 | 0.010 |
Why?
|
| Glucose | 1 | 1995 | 683 | 0.010 |
Why?
|
| Radiography | 1 | 1994 | 794 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1992 | 102 | 0.010 |
Why?
|
| Diffusion | 1 | 1992 | 91 | 0.010 |
Why?
|
| Perfusion | 1 | 1993 | 261 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 681 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 1052 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 1990 | 20 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1996 | 1241 | 0.000 |
Why?
|
| Sulfur Hexafluoride | 1 | 1988 | 4 | 0.000 |
Why?
|
| Biophysical Phenomena | 1 | 1988 | 123 | 0.000 |
Why?
|
| Biophysics | 1 | 1988 | 153 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1996 | 996 | 0.000 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1987 | 6 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1987 | 12 | 0.000 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1987 | 8 | 0.000 |
Why?
|
| Mouth Mucosa | 1 | 1987 | 68 | 0.000 |
Why?
|
| Dinoprost | 1 | 1987 | 26 | 0.000 |
Why?
|
| Leukotriene E4 | 1 | 1987 | 3 | 0.000 |
Why?
|
| Calorimetry | 1 | 1986 | 16 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1987 | 173 | 0.000 |
Why?
|
| Cineradiography | 1 | 1985 | 25 | 0.000 |
Why?
|
| Homeostasis | 1 | 1984 | 452 | 0.000 |
Why?
|
| Glucosephosphates | 1 | 1978 | 3 | 0.000 |
Why?
|
| Fructosephosphates | 1 | 1978 | 3 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1978 | 48 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1978 | 108 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1978 | 176 | 0.000 |
Why?
|
| Organophosphorus Compounds | 1 | 1978 | 53 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1978 | 251 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1978 | 760 | 0.000 |
Why?
|